Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Process for synthesizing glimepiride raw material medicine

A synthesis process and technology of APIs, which are applied in the directions of drug combinations, pharmaceutical formulations, organic active ingredients, etc., can solve the problems of incomplete reaction, complicated products, complicated methods, etc., so as to reduce the generation of isomer impurities and improve the yield. efficiency and production efficiency, and the effect of simple purification operations

Inactive Publication Date: 2018-08-10
江西博雅欣和制药有限公司
View PDF10 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] In the third step of ammoniation, the long reaction time and high reaction temperature reported in the above documents cause the hydrolysis of intermediate 2; in addition, the amount of ammonia water is also very large, which increases the cost of wastewater treatment
Intermediate 3 crude product recrystallization method, but there is no report in the existing literature, WO2006103690 uses a mixed solvent, and the method of steaming most of it after reflux is cumbersome; Shandong Chemical Industry 2009, 38 (6): 14-16 reports that 95% Ethanol is recrystallized twice to achieve 99% purity
[0006] In the fourth step addition 2, the literature reports that acetone or acetone-toluene mixed solvent is used. This method takes a long time and the reaction is incomplete, resulting in the formation of viscous precipitate, which makes filtration difficult.
In addition, acetone is a flammable, explosive and volatile solvent, which is not conducive to recovery and safe operation
[0007] In the fifth step of removing insoluble matter, Shandong Chemical Industry 2009, 38 (6): 14-16, CN101671290, and WO2006103690 all acidify Glimepiride metal hydrochloride, dry it, and then use methanol as a solvent. The weak acidity of urea forms a salt with ammonia or methanol amine to dissolve, filter out the insoluble matter, and then acidify with acetic acid or hydrochloric acid. This operation is complicated and may easily cause more inorganic salts in the product, which need to be washed many times with water to remove
According to CN101486674 operation, a large amount of carbon dioxide gas will be produced during acidification, which is prone to material spraying accidents and causes great potential safety hazards

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for synthesizing glimepiride raw material medicine
  • Process for synthesizing glimepiride raw material medicine
  • Process for synthesizing glimepiride raw material medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0096] The technical solutions of the present invention will be described in detail below in conjunction with specific embodiments.

[0097] Step 1: Addition I

[0098] Add 12kg of toluene, 5.0kg of compound A, and 7.06kg of compound B into a 50L glass reactor; start stirring and heating, and heat up to 120-130°C for reflux reaction for 2 hours; take samples and send them to HPLC for central control; after the reaction, cool down to 20- Filter at 25°C; vacuum-dry the filter cake to obtain 9.25 kg of solid intermediate 1, with an HPLC purity of >99% and a molar yield of 85%. The filtrate was directly applied to the next batch of addition I reaction, and the above operation was repeated to obtain 10.33 kg of intermediate 1 with a HPLC purity of >99% and a molar yield of 97%.

[0099] The second step: sulfonation

[0100] Add 53.10kg of dichloromethane and 10.23kg of intermediate 1 into a 100L glass reactor, start stirring, cool down to -5-0°C, slowly add 17.58Kg of chlorosulfo...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a process for synthesizing a glimepiride raw material medicine. A compound A, namely 3-ethyl-4-methyl-3-pyrroline-2-ketone and a compound B, namely 2-phenethyl isocyanate are taken as start raw materials. The process is characterized in that when an intermediate 1 is synthesized, filtrate is applied mechanically, so that the loss of the intermediate 1 can be reduced, the yield can be increased, and the production efficiency can be improved; when an intermediate 2 is synthesized, hydrochloric ether is adopted as a solvent, so that isomer impurities can be greatly reduced, the content of the isomer impurities can be reduced to 0.5% or less from 8%, and later purification procedures can be simple to operate; when a glimepiride metallic salt is synthesized, acetonitrileis adopted as a solvent, sufficient reactions can be achieved, the reaction time can be greatly shortened, the residue of an intermediate 3 is reduced to 0.2% or less from 5-10%, in addition, a highsolvent recycling rate can be achieved. The process disclosed by the invention is simple and safe, low in production cost, high in yield, stable in intermediate and finished product quality and applicable to industrial large-scale production and hypoglycemic drug, namely glimepiride, synthesis processes with relatively great social, economic and environmental-friendly benefits.

Description

technical field [0001] The invention relates to a new synthesis process of glimepiride bulk drug, which belongs to the technical field of drug synthesis. Background technique [0002] Glimepiride (glimepiride), a new sulfonylurea hypoglycemic drug, was first developed by the German company Hoechst, initially listed in Germany, and later listed in Switzerland, Sweden, Denmark and other countries. It was approved by the United States in 1995. Approved by the FDA, in 2000, it was developed, produced and launched by many manufacturers in China. Compared with other sulfonamide drugs, it has the advantages of strong hypoglycemic effect, small dose, long action time, small side effects, safety and reliability. [0003] There are many patent literature reports on the synthesis process of glimepiride, such as: Shandong Chemical Industry 2009, 38 (6): 14-16, the first step verification yield is only about 70%, the reason is that intermediate 1 has Certain solubility; WO2006103690 co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D207/38A61K31/4015A61P3/10
CPCA61P3/10C07D207/38
Inventor 谢西平冷志刘毅殷清华张作芳叶刚
Owner 江西博雅欣和制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products